Job
PhD or Postdoctoral Position in microRNA Decay
National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD and surrounding area
About the position
The NIH main campus in Bethesda is a vibrant and collaborative research environment boasting over four hundred research groups and an active postdoc community. Bethesda, Maryland is part of the Washington, D.C. metropolitan area, and the NIH main campus is easily accessible by the Washington, D.C. subway system.
The McJunkin lab seeks Ph.D. students and postdoctoral fellows with an interest in mechanisms of miRNA degradation. We use classical genetics and genome editing in C. elegans and mammalian cells, along with next-generation sequencing, cell biology, and biochemical techniques. For more information, please see our website (https://www.niddk.nih.gov/research-funding/at-niddk/labs-branches/laboratory-cellular-developmental-biology/section-regulatory-rnas).
Apply for this vacancy
What you'll need to apply
To apply, please send a cover letter describing which aspect of our research program you are interested to pursue, a CV, and contact information for three references to mcjunkin@nih.gov.
Contact name
Katie McJunkin
Contact email
Qualifications
Ph.D. students may join as part of an institutional Graduate Partnership Program or an Individual Graduate Partnership Program (https://www.training.nih.gov/research-training/grads/gpp/). Postdoctoral applicants must have completed a Ph.D. within the last three years. Expertise in molecular biology and strong verbal and written communication skills are required. Experience in cell culture, RNA biology or C. elegans research is desirable. International scientists and U.S. citizens are equally eligible. Students and postdocs from underrepresented or underprivileged backgrounds are encouraged to apply. Start date is flexible.
Additional Information
The NIH is dedicated to building a community in its training and employment programs and encourages the application and nomination of qualified women, minorities, and individuals with disabilities.